Skip to content
healthcare.dev

Ranolazine

NDC 90096-152, ranolazine, tablet, film coated, extended release, from Zameer Pharmaceuticals LLC.

Product NDC
90096-152
Status
Listed
Labeler
Zameer Pharmaceuticals LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213085
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/90096-152 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE1000 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
90096-152-609009601526060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (90096-152-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f4fc8a4-2bd5-4378-8882-e739c951390e
  • NADAC price for package 90096015260

    GET /v1/drugs/nadac/90096015260

Use it

Look up 90096-152 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/90096-152 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 90096-152. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.